Paolo Civitelli
Research Subjects
Research Interests
Paolo Civitelli has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Lugoboni
Medical Service for Addictive Disorders, Department of Internal Medicine, University of Verona, Italy
1 shared publication - Gianluca Quaglio
European Parliamentary Research Services (EPRS), European Parliament, Brussels, Belgium
1 shared publication - Paolo Mezzelani
Medical Unit for Addictive Disorders, Department of Internal Medicine, Policlinico GB Rossi, 37134 Verona, Italy
1 shared publication
Latest Publications
- Open Access
- 22 January 2009
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 6 (1) , 400-413
Bloodborne Viral Hepatitis Infections among Drug Users: The Role of Vaccination
Drug use is a prevalent world-wide phenomenon and hepatitis virus infections are traditionally a major health problem among drug users (DUs). HBV and HCV, and to a lesser extent HAV, are easily transmitted through exposure to infected blood and body fluids. Viral hepatitis is not inevitable for DUs. Licensed vaccines are available for hepatitis A and hepatitis B. The purpose of this overview is to show some epidemiological data about HBV and the other blood-borne viral hepatitis among DUs and to summarize and discuss use of hepatitis vaccinations in this population. Successful vaccination campaigns among DUs are feasible and well described. We try to focus on the most significant results achieved in successful vaccination programs as reported in scientific literature. Vaccination campaigns among DUs represent a highly effective form of health education and they are cost-saving.
- 22 January 2009
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 6 (1) , 400-413
Open AccessBloodborne Viral Hepatitis Infections among Drug Users: The Role of Vaccination
Drug use is a prevalent world-wide phenomenon and hepatitis virus infections are traditionally a major health problem among drug users (DUs). HBV and HCV, and to a lesser extent HAV, are easily transmitted through exposure to infected blood and body fluids. Viral hepatitis is not inevitable for DUs. Licensed vaccines are available for hepatitis A and hepatitis B. The purpose of this overview is to show some epidemiological data about HBV and the other blood-borne viral hepatitis among DUs and to summarize and discuss use of hepatitis vaccinations in this population. Successful vaccination campaigns among DUs are feasible and well described. We try to focus on the most significant results achieved in successful vaccination programs as reported in scientific literature. Vaccination campaigns among DUs represent a highly effective form of health education and they are cost-saving.